Erectile dysfunction and radiation dose to penile base structures: A lack of correlation

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 4, 2004, Pages 1039-1046

  Selek, Ugur ^a   Cheung, Rex ^a   Lii, Mingfwu ^a   Allen, Pamela ^a   Steadham, Roy E ^a   Vantreese Jr , Terry R ^a   Little, Darren J ^a   Rosen, Isaac I ^a   Kuban, Deborah ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Erectile dysfunction; Penile base; Prostate cancer; Radiotherapy

Indexed keywords

ALCOHOLS; DOSIMETRY; PATIENT TREATMENT; RADIOTHERAPY; STATISTICAL METHODS;

ERECTILE DYSFUNCTION; PENILE STRUCTURES;

ONCOLOGY;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEAM THERAPY; CALCULATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CORPUS CAVERNOSUM; CORRELATION ANALYSIS; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HISTOGRAM; HUMAN; HYPERTENSION; IMPOTENCE; MALE; MEDICAL RESEARCH; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RETROSPECTIVE STUDY; SEXUAL FUNCTION; SEXUAL INTERCOURSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PENIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 3042522620     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.028     Document Type: Article

References (42)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47
2. Oesterling J.F.Z. Cancer of prostate. Shasar V.T.D. Jr. Cancer principles and practice of oncology. vol 1. 1997;1322-1385 Lippincott-Raven, Philadelphia
3. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:1998;969-974
4. Davis J.W., Kuban D.A., Lynch D.F., et al. Quality of life after treatment for localized prostate cancer Differences based on treatment modality. J Urol. 166:2001;947-952
5. Catalona W.J., Bigg S.W. Nerve-sparing radical prostatectomy Evaluation of results after 250 patients. J Urol. 143:1990;538-544
6. Catalona W.J., Dresner S.M. Nerve-sparing radical prostatectomy Extraprostatic tumor extension and preservation of erectile function. J Urol. 134:1985;1149-1151
7. Walsh P.C., Donker P.J. Impotence following radical prostatectomy Insight into etiology and prevention. J Urol. 128:1982;492-497
8. Walsh P.C. Radical prostatectomy, preservation of sexual function, cancer control The controversy. Urol Clin North Am. 14:1987;663-673
9. Finkle A.L. Sexual potency A pioneer's thirty-five-year overview. Urology. 32:1988;511-515
10. Fowler F.J. Jr, Barry M.J., Lu-Yao G., et al. Patient-reported complications and follow-up treatment after radical prostatectomy The National Medicare experience - 1988-1990 (updated June 1993). Urology. 42:1993;622-629
11. Litwin M.S., Flanders S.C., Pasta D.J., et al. For the Cancer of the Prostate Strategic Urologic Research Endeavor. Sexual function and bother after radical prostatectomy or radiation for prostate cancer Multivariate quality-of-life analysis from CaPSURE. Urology. 54:1999;503-508
12. Jonler M., Messing E.M., Rhodes P.R., et al. Sequelae of radical prostatectomy. Br J Urol. 74:1994;352-358
13. Stanford J.L., Feng Z., Hamilton A.S., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer the Prostate Cancer Outcomes Study. JAMA. 283:2000;354-360
14. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468
15. Mantz C.A., Song P., Farhangi E., et al. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;551-557
16. Mantz C.A., Nautiyal J., Awan A., et al. Potency preservation following conformal radiotherapy for localized prostate cancer Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors. Cancer J Sci Am. 5:1999;230-236
17. Beard C.J., Lamb C., Buswell L., et al. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;257-262
18. Beard C.J., Propert K.J., Rieker P.P., et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients A prospective multiinstitutional outcomes study. J Clin Oncol. 15:1997;223-229
19. Crook J., Esche B., Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function The patient's perspective. Urology. 47:1996;387-394
20. Hanks G.E., Teshima T., Pajak T.F. 20 Years of progress in radiation oncology prostate cancer. Semin Radiat Oncol. 7:1997;114-120
21. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 53:2002;1097-1105
22. Fisch B.M., Pickett B., Weinberg V., et al. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology. 57:2001;955-959
23. DiBiase S.J., Wallner K., Tralins K., et al. Brachytherapy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys. 46:2000;1301-1307
24. Mulhall J.P., Yonover P.M. Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer. [Letter] Urology. 58:2001;828
25. Mulhall J.P., Yonover P., Sethi A., et al. Radiation exposure to the corporeal bodies during 3-dimensional conformal radiation therapy for prostate cancer. J Urol. 167:2002;539-542
26. Roach M.I. Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer. Reply by the authors [Letter]. Urology. 58:2001;828
27. Kiteley R.A., Lee W.R., DeGuzman A.F., et al. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy. 1:2002;90-94
28. Merrick G.S., Butler W.M., Wallner K.E., et al. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys. 54:2002;1055-1062
29. Merrick G.S., Wallner K., Butler W.M., et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 50:2001;597-604
30. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642
31. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 54:2002;1314-1321
32. Wallner K.E., Merrick G.S., Benson M.L., et al. Penile bulb imaging. Int J Radiat Oncol Biol Phys. 53:2002;928-933
33. Wachter S., Wachter-Gerstner N., Bock T., et al. Interobserver comparison of CT and MRI-based prostate apex definition Clinical relevance for conformal radiotherapy treatment planning. Strahlenther Onkol. 178:2002;263-268
34. Armitage P.B.G. Statistical methods in medical research. 3rd ed :1994;Blackwell Scientific, Oxford, England
35. Chen C.T., Valicenti R.K., Lu J., et al. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiat Oncol Biol Phys. 50:2001;591-595
36. Zelefsky M.J., Eid J.F. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys. 40:1998;129-133
37. Johannes C.B., Araujo A.B., Feldman H.A., et al. Incidence of erectile dysfunction in men 40 to 69 years old Longitudinal results from the Massachusetts Male Aging Study. J Urol. 163:2000;460-463
38. Moreira E.D. Jr, Lbo C.F., Diament A., et al. Incidence of erectile dysfunction in men 40 to 69 years old: Results from a population-based cohort study in Brazil. Urology. 61:2003;431-436
39. Vijayakumar S., Myrianthopoulos L.C., Dabrowski J., et al. In the radiotherapy of prostate cancer, technique determines the doses to the penile structures. Br J Radiol. 72:1999;882-888
40. Weil M.D., Crawford E.D., Cornish P., et al. Minimal toxicity with 3-FAT radiotherapy of prostate cancer. Semin Urol Oncol. 18:2000;127-132
41. Sethi A., Mohideen N., Leybovich L., et al. Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys. 55:2003;970-978
42. Merrick G.S., Butler W.M., Dorsey A.T., et al. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 48:2000;1069-1074